Novartis with new approval


The US Food and Drug Administration granted Novartis an extended approval for its drug Promacta. This medicine helps in severe aplastic anemia. This is a disease of the hematopoietic system characterized by a decrease in all blood cells and a low hematopoietic cell count in the bone marrow. At the end of the week, the FDA has now given its extended approval, …Read the full article …


Source link